This invention provides estrogen receptor modulators of formula I, having the structure 1 where R.sup.1 R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7 and R.sup.8 are as defined in the specification.

 
Web www.patentalert.com

< Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use

< Pyrrolotriazine kinase inhibitors

> Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders

> Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl- ]methoxy] benzyl]thiazolidine-2,4-dione potassium salt
~ 00216